Cargando…
Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis
Germline HAVCR2 mutations are frequently detected in subcutaneous panniculitis-like T-cell lymphoma (SPTCL) patients with/without hemophagocytic lymphohistiocytosis (HLH) but factors associated with variable manifestations remain undetermined. To evaluate clinical variations and associated factors i...
Autores principales: | Moonla, Chatphatai, Polprasert, Chantana, Komvilaisak, Patcharee, Rattanathammethee, Thanawat, Kongkiatkamon, Sunisa, Wudhikarn, Kitsada, Kobbuaklee, Sirorat, Boonyabaramee, Pitchayut, Tangcheewinsirikul, Nuanrat, Pakakasama, Samart, Rujkijyanont, Piya, Choed-Amphai, Chane, Phuakpet, Kamon, Pongudom, Saranya, Bunworasate, Udomsak, Sukswai, Narittee, Sosothikul, Darintr, Rojnuckarin, Ponlapat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543163/ https://www.ncbi.nlm.nih.gov/pubmed/37051767 http://dx.doi.org/10.3324/haematol.2022.282419 |
Ejemplares similares
-
P1238: GERMLINE HAVCR2 MUTATIONS AND THEIR RELATION TO THE CLINICAL SPECTRUM OF SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: RESULTS FROM A MULTICENTER STUDY
por: Polprasert, Chantana, et al.
Publicado: (2023) -
Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes
por: Hattakitpanitchakul, Saroj, et al.
Publicado: (2021) -
Anticoagulation and In-Hospital Mortality From Coronavirus Disease
2019: A Systematic Review and Meta-Analysis
por: Moonla, Chatphatai, et al.
Publicado: (2021) -
Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021) -
P1189: ENDOTHELIAL ACTIVATION AND STRESS INDEX IS AN INDEPENDENT PROGNOSTIC FACTOR OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD IMMUNOCHEMOTHERAPY
por: Thanhakun, Ronakrit, et al.
Publicado: (2023)